Pharmaceutical

Pharmaceutical clean room manufacturing, flooring and d...

Discover the key factors and latest advancements in pharmaceutical clean room ma...

Final report says UK infected blood scandal “should hav...

Nearly 30,000 people, including children in clinical trials, were infected with ...

Amgen and AstraZeneca ponder label expansion for Tezspi...

The companies plan to start Phase III trials for Tezspire in COPD despite missin...

UK clinical trials industry tackles recent changes in t...

The Annual Outsourcing in Clinical Trials conference will gather pharma experts ...

Cervical cancer elimination in the UK is within sight w...

A recent study in England has shown that the HPV vaccine in teenagers reduced th...

How to identify and remove CNS assessment errors to avo...

Integrating speech analysis for automated quality assurance provides can help id...

Cold chain storage and distribution for the pharmaceuti...

Download our comprehensive list of leading cold chain storage and distribution s...

Q1 2024 update: individualism & expression related M&A ...

In the global pharmaceutical industry, there were 2 M&A deals announced in Q1 20...

How future of work private equity performed in the phar...

In the global pharmaceutical industry, there were 3 private equity deals announc...

Q1 2024 update: personalization related M&A activity in...

In the global pharmaceutical industry, there were 2 M&A deals announced in Q1 20...

Q1 2024 update: M&A activity in pharmaceutical in Sweden

In Sweden pharmaceutical industry, there were 6 M&A deals announced in Q1 2024, ...

Moxifloxacin by Laboratorios Sophia for Bacterial Conju...

Moxifloxacin is under clinical development by Laboratorios Sophia and currently ...

TNT-119 by Eliem Therapeutics for Membranous Glomerulon...

TNT-119 is under clinical development by Eliem Therapeutics and currently in Pha...

IL13R alpha 2 CAR-T by TCR Cure Biopharma Technology fo...

IL13R alpha 2 CAR-T is under clinical development by TCR Cure Biopharma Technolo...

Direct to consumer channels change patient-healthcare s...

With patients taking control over health, experts discuss how different players ...

J&J expands dermatology portfolio with $850m Proteologi...

J&J has gained access to several bispecific antibody programmes, including the P...